Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target
Trulieve Cannabis Corp.
Trulieve Cannabis Corp. TRLV | 0.00 |
Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:
TRLV) with a Overweight and maintains $15 price target.
